ULTRALIFE CORP (ULBI) - Form 8-K Summary
Business Context and Reporting Period
Ultralife Corporation, a Delaware corporation headquartered in Newark, New York, filed this Current Report on Form 8-K on November 18, 2025. The filing serves to announce the financial results for the third quarter ended September 30, 2025, via a press release incorporated as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are referenced as being contained within the attached press release (Exhibit 99.1) but are not present in the cover page text provided.
Material Changes
No specific material changes versus the prior comparable period are detailed in the filing text. The document solely indicates that results for the third quarter of 2025 have been issued.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, forward-looking guidance, specific risk factors, contingencies, or unusual items. Investors must refer to the attached press release for these details.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2025 revenue and earnings figures.
- Verify year-over-year and quarter-over-quarter performance trends in the full press release.
- Check for any updated full-year 2025 guidance or outlook statements in the attached exhibit.
- Confirm the absence of any unusual items or restatements in the detailed financial disclosure.